NIDHI BANSAL's research topics

NIDHI BANSAL

Concepts (58)

Back to Profile

Concepts are derived automatically from a person's publications.

The timeline below shows the dates (blue tick marks) of publications associated with NIDHI BANSAL's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that NIDHI BANSAL has written about over time.

Hydroxymethylglutaryl-CoA Reductase Inhibitors, 3 publications between 2005 and 2023, average publication date April 2011. Dwarfism, 1 publications between 2011 and 2011, average publication date November 2011. Growth Disorders, 1 publications between 2011 and 2011, average publication date November 2011. Human Growth Hormone, 1 publications between 2011 and 2011, average publication date November 2011. Diet, 1 publications between 2013 and 2013, average publication date July 2013. Diabetes Mellitus, Type 1, 3 publications between 2013 and 2016, average publication date April 2015. Autoantibodies, 1 publications between 2016 and 2016, average publication date February 2016. C-Peptide, 1 publications between 2016 and 2016, average publication date February 2016. Glutamate Decarboxylase, 1 publications between 2016 and 2016, average publication date February 2016. Receptor-Like Protein Tyrosine Phosphatases, Class 8, 1 publications between 2016 and 2016, average publication date February 2016. Zinc Transporter 8, 1 publications between 2016 and 2016, average publication date February 2016. Cardiovascular Diseases, 3 publications between 2005 and 2023, average publication date April 2017. Risk Factors, 3 publications between 2005 and 2023, average publication date April 2017. Child, 5 publications between 2011 and 2023, average publication date March 2018. Adolescent, 5 publications between 2013 and 2023, average publication date July 2018. Atherosclerosis, 1 publications between 2023 and 2023, average publication date February 2023. Hyperlipidemias, 1 publications between 2023 and 2023, average publication date February 2023. Hypolipidemic Agents, 1 publications between 2023 and 2023, average publication date February 2023. Dyslipidemias, 2 publications between 2023 and 2023, average publication date April 2023. Hyperlipoproteinemia Type II, 1 publications between 2023 and 2023, average publication date July 2023.

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Dwarfism
Growth Disorders
Human Growth Hormone
Diet
Diabetes Mellitus, Type 1
Autoantibodies
C-Peptide
Glutamate Decarboxylase
Receptor-Like Protein Tyrosine Phosphatases, Class 8
Zinc Transporter 8
Cardiovascular Diseases
Risk Factors
Child
Adolescent
Atherosclerosis
Hyperlipidemias
Hypolipidemic Agents
Dyslipidemias
Hyperlipoproteinemia Type II

To see the data from this visualization as text, click here.

Name	Number of Publications	First Publication Year	Most Recent Publication Year	Average Publication Date
Hydroxymethylglutaryl-CoA Reductase Inhibitors	3	2005	2023	April 2011
Dwarfism	1	2011	2011	November 2011
Growth Disorders	1	2011	2011	November 2011
Human Growth Hormone	1	2011	2011	November 2011
Diet	1	2013	2013	July 2013
Diabetes Mellitus, Type 1	3	2013	2016	April 2015
Autoantibodies	1	2016	2016	February 2016
C-Peptide	1	2016	2016	February 2016
Glutamate Decarboxylase	1	2016	2016	February 2016
Receptor-Like Protein Tyrosine Phosphatases, Class 8	1	2016	2016	February 2016
Zinc Transporter 8	1	2016	2016	February 2016
Cardiovascular Diseases	3	2005	2023	April 2017
Risk Factors	3	2005	2023	April 2017
Child	5	2011	2023	March 2018
Adolescent	5	2013	2023	July 2018
Atherosclerosis	1	2023	2023	February 2023
Hyperlipidemias	1	2023	2023	February 2023
Hypolipidemic Agents	1	2023	2023	February 2023
Dyslipidemias	2	2023	2023	April 2023
Hyperlipoproteinemia Type II	1	2023	2023	July 2023

BANSAL's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (58)

Explore

Co-Authors (3)

Explore

Similar People (60)

Explore

Same Department

Explore

Physical Neighbors